Literature DB >> 6773528

Inhibition of monoamine oxidase by d-methamphetamine.

O Suzuki, H Hattori, M Asano, M Oya, Y Katsumata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6773528     DOI： 10.1016/0006-2952(80)90493-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

1.  Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.

Authors:  Matthias Löhle; Heinz Reichmann
Journal:  BMC Neurol       Date:  2011-09-22       Impact factor: 2.474

Review 2.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

3.  Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.

Authors:  Kelly M Lohr; Kristen A Stout; Amy R Dunn; Minzheng Wang; Ali Salahpour; Thomas S Guillot; Gary W Miller
Journal:  ACS Chem Neurosci       Date:  2015-03-09       Impact factor: 4.418

4.  Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling.

Authors:  Renee L Good; Li-Ping Liang; Manisha Patel; Richard A Radcliffe
Journal:  Neurotoxicology       Date:  2011-07-20       Impact factor: 4.294

Review 5.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11

6.  Lobelane decreases methamphetamine self-administration in rats.

Authors:  Nichole M Neugebauer; Steven B Harrod; Dustin J Stairs; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  Eur J Pharmacol       Date:  2007-06-13       Impact factor: 4.432

7.  Effects of the GluN2B-selective antagonist Ro 63-1908 on acquisition and expression of methamphetamine conditioned place preference in male and female rats.

Authors:  Justin R Yates; Hunter L Campbell; Lauren L Hawley; Matthew J Horchar; Joy L Kappesser; Makayla R Wright
Journal:  Drug Alcohol Depend       Date:  2021-05-26       Impact factor: 4.852

8.  The effects of locus coeruleus and norepinephrine in methamphetamine toxicity.

Authors:  Michela Ferrucci; Filippo S Giorgi; Alessia Bartalucci; Carla L Busceti; Francesco Fornai
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

9.  Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community.

Authors:  Maryam Bagheri; Azarakhsh Mokri; Aliakbar Khosravi; Kourosh Kabir
Journal:  Int J High Risk Behav Addict       Date:  2015-09-01

Review 10.  Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress.

Authors:  Fiona Limanaqi; Stefano Gambardella; Francesca Biagioni; Carla L Busceti; Francesco Fornai
Journal:  Oxid Med Cell Longev       Date:  2018-07-22       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.